For this special Coffee Talk, I invited Sophie Park, Chief Strategist for Bayer G4A Partnerships to discuss the opportunities for innovative companies to grow and partner with a global pharma company.
The Bayer G4A program has continued to grow and succeed since 2013, and it has evolved to adapt to changing market forces, new business priorities and the unprecedented acceleration of innovation that has taken place at the intersection of health and technology. 
One of the challenges when an organization has a long history of success like that is that people begin to automatically associate what they knew about the program in previous years, and then overlay that to make presumptions about what the program is like this year.  For example - a lot of people think that G4A is simply an accelerator for early stage startups. In actual fact, they also have a very powerful partnership program which is designed to attract companies that can participate in joint ventures, commercial partnerships or even majority investments.  
In this episode, we dispel some of these myths and give more insights on the progress and success of the G4A program and family.

Learn more about Bayer G4A Partnership

Links and Resources:
Learn more about Bayer G4A: Web | Twitter


Connect on Digital Health Today:
Browse Episodes | Twitter | Linkedin | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | Linkedin | Twitter | Facebook | Instagram
 
Digital Health Today is made possible by the support of our sponsors. Thank you to

University of Chicago - Master of Science in Biomedical Informatics

Almirall Digital Garden

Bayer G4A

Cedars-Sinai Accelerator

Medable


Learn more about your ad choices. Visit megaphone.fm/adchoices

Coffee Talk: How Innovative Companies can Partner with a Global Pharma Brand

Digital Health Today 360 features the innovators, leaders and pioneers reshaping health and wellness. From patients and clinicians, to inventors and investors, we speak with guests from around the world to share their insights, experience and knowledge from the front lines of health tech innovation. Tune in, follow and become a part of the digital health community. Proud Member: Health Podcast Network.

Technology

Tech News

Podcasting

Gadgets

Software How-To

Business

Investing

Careers

Management & Marketing

Business News

Shopping

Medicine

Science & Medicine

Marketing

Health & Fitness

Women and girls in low/middle-income countries are facing an urgent unmet need for modern contraception. This World Contraception Day, join guest host Sophie Park, Managing Director at G4A Digital Health Bayer in conversation with Dr. Ariane de Hoog, Lead Access to Medicine, Community Engagement at Bayer, and Titilola Olaolu-Hassan, Co-Founder & COO at Zuri Health, for this vital discussion on harnessing digital health solutions to empower women and enhance healthcare accessibility in Africa.

Topics include:
[00:02:14] Background to Bayer’s interest in empowering Women’s health.
[00:05:05] Zuri Health: Affordable healthcare for underserved communities.
[00:06:28] Impact goals behind Zuri becoming a G4A Portfolio company.
[00:11:37] How the Zuri Health platform directly improves girls' and women's access to healthcare.
[00:14:08] The future beyond family planning for Zuri Health in partnership with Bayer.
[00:15:53] Bayer’s impact goal to provide 100 million women access to modern contraception by 2030.
[00:20:23] Empowering women to make informed decisions irrespective of location

Guest & Host Links

Connect with Dan Kendall on LinkedIn


Connect with Sophie Park on LinkedIn


Connect with Dr. Ariane de Hoog on LinkedIn


Connect with Titilola Olaolu-Hassan on LinkedIn


Bayer G4A


Zuri Health - 


Your-Life website - complimentary access to an array of educational and training resources on adolescent health and contraceptive counselling


Digital Health Today would not be possible without the support of leading organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Partners and Sponsors: LSI | Lindus Health | Bayer G4A

Connect on Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | Linkedin | Twitter | Facebook | Instagram
Learn more about your ad choices. Visit megaphone.fm/adchoices

S13: #116: Empowering Women's Health through Access to Contraception in Low/Middle Income Countries

The Digital Medicine Society (DiMe) and Moffitt Cancer Center have announced they are co-hosting CancerX, a new public-private partnership effort to rapidly accelerate the pace of cancer innovation in the U.S.
Alongside the Office of the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH), Moffitt Cancer Center and DiMe are urging the healthcare and digital health sectors to boost technology-driven initiatives to combat cancer. The two groups are working together to accelerate cancer research advancements, and they invite other organizations to do the same.
The Biden administration's revived Cancer Moonshot includes the new CancerX public-private partnership. According to officials, the goal is to use industry collaboration and disruptive innovation to lessen the burden of cancer on everyone.
The CancerX program will focus on using digital innovation to reduce disparities and financial toxicity in cancer care and research, working with government organizations, and will enlist industry parties to help with the mammoth undertaking.
CancerX uniquely blends DiMe’s expertise in convening cross-disciplinary groups to develop clinical-quality resources on a tech timeline with Moffitt’s top research and care experts working side-by-side to revolutionize cancer treatment, extend access to the highest-quality care, and save more lives. The initiative is open to all those working in the field who are committed to working collaboratively and share a vision of unleashing the power of innovation to design and create a future that's free of the burden of cancer.
Topics include:

What is the Digital Medicine Society?

Announcing CancerX, key initiatives and membership structure

Improving the global ecosystem


Guest & Host Links


Connect with Dan Kendall | LinkedIn 



Connect with Jennifer Goldsack | LinkedIn and listen to her episode from May 2019


CancerX

Digital Medicine Society

Dime Academy 

DiMe Society Slack


Digital Health Today would not be possible without the support of leading organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Partners and Sponsors: Akili | Lindus Health | Bayer G4A

Connect on Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | Linkedin | Twitter | Facebook | Instagram
Learn more about your ad choices. Visit megaphone.fm/adchoices

S13: #115: CancerX Initiative Aims to Reduce Cancer Deaths by 50% by 2047

In this coffee talk with AmalgamRX we dive into the challenges being faced by health systems as they work to assess, develop, and implement solutions at the time of a clinical decision. We'll explore the major pain points that keep projects from reaching their full potential, what it takes to overcome these challenges and what you can do when you're developing a digital therapeutic solution for your organization. There's also some tips that apply to payers and pharma as they play a key role in the successful development and implementation of digital therapies.
Guest Links and Resources:

Connect with Jenni Main on LinkedIn


Connect with Dr. Suzanne Clough on LinkedIn


Visit https://amalgamrx.com/



Host Links:

Connect with Dan Kendall: Twitter | LinkedIn


Connect with Eugene Borukhovich: Twitter | LinkedIn



Connect on Digital Health Today:
Browse Episodes | Twitter | Linkedin | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | Linkedin | Twitter | Facebook | Instagram
Learn more about your ad choices. Visit megaphone.fm/adchoices

Coffee Talk: Implementing Solutions for Health Systems with AmalgamRX

I’m glad to be back on the mic and bringing you this special episode of Digital Health Today 360. Why is this episode special? Let me explain.

One of the goals of the Digital Health Today channel is to create a space where people can learn about great innovation that can improve the health of both individuals and entire populations. 

Over the years, as I’ve been creating my own show, I’ve also had the opportunity to expand and serve the health community in other ways. Along with my colleagues at Mission Based Media, we’ve created other audio-first resources to share more information. For example, we created Health Podcast Network to showcase other high-quality, human-centered and evidence-based podcasts. Health Podcast Network now has about 100 different health podcasts and 13,000 episodes. 

We also worked through the pandemic to add new shows to Digital Health Today such as the DTx Podcast with Eugene Borukhovich, where he dives into the nascent digital therapeutics industry.

And, most recently, we launched a library of podcasts called Health Unmuted where we create and share short-format, narrated, audio stories to help people understand more about specific health conditions. We launched the proof-of-concept miniseries last year called COPD Podcast. In June we launched the 5-part miniseries about Alzheimer’s Disease, and this month, in July, we’ll launch a 7-part miniseries about Parkinson’s disease.

Why am I explaining all this? Because all this work at the intersection of health and podcasting has given me a chance to experiment with different formats, styles, content and audiences, and it’s also made me realize that I love creating this show.  

It’s also made me more aware than ever that there is so much more that needs to be shared.  

So, in this special episode, as I fire up the recording studio and prepare some great conversations with guests over the coming weeks and months, I thought I’d stand aside and invite another podcaster who is doing some great work in an area that needs much more attention.  

Georgie Kovacs is the founder and host of Fempower Health - the go-to resource for all things women’s health serving women, their providers, and companies looking to build and improve on products for women. Georgie is really open about her first-hand experience with infertility and endometriosis. With that experience, she was motivated to start a podcast - in the middle of COVID, and as a single parent. Now if that’s not passion, I don’t know what is.

You can find her show, Fempower Health, on Health Podcast Network.

In this special episode, Georgie spoke with Dr. Michal Elovitz. Dr. Elovitz is the Distinguished Professor in Women’s Health at the Perelman School of Medicine at the University of Pennsylvania and she’s also the Chief Medical Advisor at Mirvie, a company creating a personalized window into pregnancy health.  

When it comes to women’s health, I’ve been astonished at the tremendous need for improvement, funding and resources, and at the same time, I’ve also seen some incredible innovation that is happening that needs more attention, awareness and funding!

And despite the U.S. having the highest maternal mortality rate among developed countries, health risks in pregnancy health have remained understudied, underfunded, and underserved. Pregnancy complications such as preeclampsia, preterm birth and gestational diabetes impact 1 in 5 women, and with no accurate way to predict them before symptoms appear, both moms and babies are often in crisis mode when diagnosed in their third trimester. 

In their conversation, Georgie and Dr. Elovitz explain one of those complications, preeclampsia, and explore how better screening can help.

Let me know what you think of this episode. Drop me a line on Twitter or LinkedIn and let me know!

More great episodes of DHT360 are on the way, so be sure to hit follow on your favorite podcast app.  

Thanks for tuning in!
Learn more about your ad choices. Visit megaphone.fm/adchoices

Guest Host: The Progress and Promise of Predicting Complications in Pregnancy

Technology is under the microscope, as are the behaviors of the people who develop and deploy it.

As technology impacts virtually every aspect of society, it's use within the life sciences goes beyond traditional bioethical topics. 

This creates a host of questions for people and businesses working at the forefront of health innovation.

In this episode, hear Nick Bott, Global Head, Bioethics and Technology Ethics at Takeda as we discuss:

What is being done to ensure that the decisions around the use of technology for our health and wellbeing are carefully considered and applied? 

Whose job is it to address the ethical questions in the development of AI and ML algorithms? 

How can life science companies lead the way in setting standards for ethical development?

What can we learn from Tony Stark - otherwise known as Iron Man in the Marvel Cinematic Universe?

What is a 'consequence scanning workshop'?

What is the role of regulation in setting standards and principles?


Episode Links and Resources:

Learn More About Ethics and Compliance at Takeda


Notre Dame-IBM Technology Ethics Lab

Markkula Center for Applied Ethics at Santa Clara University

About the Age of Ultron - a lesson in 'irresponsible innovation'?

Hear the Coffee Talk about the Health Outcomes Observatory (H2O)



Guest Host Links
Connect with Nick Bott on LinkedIn


Connect on Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | Linkedin | Twitter | Facebook | Instagram

Digital Health Today is made possible by the support of our sponsors. Thank you to:

Bayer G4A

Roche

Takeda


Learn more about your ad choices. Visit megaphone.fm/adchoices

Coffee Talk: How Innovative Companies can Partner with a Global Pharma Brand

Download our free app to listen on your phone